Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-09-13 Sale |
2023-09-14 4:14 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
12,401 | $1.3257 | $16,440 | 596,241 (Direct) |
View |
2023-09-13 Sale |
2023-09-14 4:14 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
6,411 | $1.3257 | $8,499 | 249,559 (Direct) |
View |
2023-09-13 Sale |
2023-09-14 4:13 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
8,998 | $1.3257 | $11,929 | 378,087 (Direct) |
View |
2023-09-13 Sale |
2023-09-14 4:13 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks |
2,505 | $1.3257 | $3,321 | 85,520 (Direct) |
View |
2023-09-13 Sale |
2023-09-14 4:13 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
17,830 | $1.3257 | $23,637 | 976,614 (Indirect Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:30 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
115 | $0.3481 | $40 | 147,514 (Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:30 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
115 | $0.3481 | $40 | 147,514 (Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:29 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director |
115 | $0.3481 | $40 | 147,514 (Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:29 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
115 | $0.3481 | $40 | 147,514 (Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:28 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
115 | $0.3481 | $40 | 152,501 (Direct) |
View |
2023-06-14 Sale |
2023-06-15 4:28 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director |
115 | $0.3481 | $40 | 147,514 (Direct) |
View |
2023-02-15 Sale |
2023-02-17 4:21 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
3,173 | $0.5418 | $1,719 | 227,018 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 5:29 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
24,661 | $0.5978 | $14,742 | 513,204 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 5:28 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
17,769 | $0.5978 | $10,622 | 324,736 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 5:26 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
12,663 | $0.5978 | $7,570 | 214,848 (Direct) |
View |
2023-01-23 Sale |
2023-01-25 5:25 pm |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
35,453 | $0.5978 | $21,194 | 866,127 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-10-10 Equity Swap |
2023-10-11 10:17 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks |
115,520 | $0 | 0 (Direct) |
View |
2023-10-10 Option Award |
2023-10-11 10:17 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks |
30,000 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:12 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
75,778 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:12 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
548,087 | $0 | 0 (Direct) |
View |
2023-10-10 Option Award |
2023-10-11 10:12 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
170,000 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:08 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
766,241 | $0 | 0 (Direct) |
View |
2023-10-10 Option Award |
2023-10-11 10:08 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
170,000 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:07 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
75,778 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:05 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
369,559 | $0 | 0 (Direct) |
View |
2023-10-10 Option Award |
2023-10-11 10:05 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
120,000 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:03 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director |
75,778 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 10:02 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
312,018 | $0 | 0 (Direct) |
View |
2023-10-10 Option Award |
2023-10-11 10:02 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
85,000 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 09:58 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
80,765 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 09:58 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
75,778 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 09:52 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
1,216,614 | $0 | 0 (Direct) |
View |
2023-10-10 Option Award |
2023-10-11 09:52 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
240,000 | $0 | 0 (Direct) |
View |
2023-10-10 Equity Swap |
2023-10-11 09:52 am |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director |
75,778 | $0 | 0 (Direct) |
View |
2023-09-12 Option Award |
2023-09-14 4:14 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
45,000 | $0 | 596,241 (Direct) |
View |
2023-09-12 Option Award |
2023-09-14 4:14 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
22,200 | $0 | 249,559 (Direct) |
View |
2023-09-12 Option Award |
2023-09-14 4:13 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
31,200 | $0 | 378,087 (Direct) |
View |
2023-09-12 Option Award |
2023-09-14 4:13 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks |
9,000 | $0 | 85,520 (Direct) |
View |
2023-09-12 Option Award |
2023-09-14 4:13 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
64,747 | $0 | 976,614 (Direct) |
View |
Ownership |
2023-08-15 4:05 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks |
0 | $0 | 221,775 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:30 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director |
119,560 | $0 | 147,514 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:30 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director |
119,560 | $0 | 147,514 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:29 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director |
119,560 | $0 | 147,514 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:29 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director |
119,560 | $0 | 147,514 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:28 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director |
119,560 | $0 | 152,501 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 4:28 pm |
N/A 2033-06-13 |
Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director |
119,560 | $0 | 147,514 (Direct) |
View |
2023-02-07 Option Award |
2023-02-09 5:20 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
14,926 | $0 | 233,770 (Direct) |
View |
2023-02-08 Tax Withholding |
2023-02-09 5:20 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
5,145 | $0.5965 | 233,770 (Direct) |
View |
2023-02-07 Option Award |
2023-02-09 5:11 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
22,547 | $0 | 355,885 (Direct) |
View |
2023-02-08 Tax Withholding |
2023-02-09 5:11 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
6,544 | $0.5965 | 355,885 (Direct) |
View |
2023-02-07 Option Award |
2023-02-09 5:11 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
36,044 | $0 | 563,642 (Direct) |
View |
2023-02-08 Tax Withholding |
2023-02-09 5:11 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
9,973 | $0.5965 | 563,642 (Direct) |
View |
2023-02-07 Option Award |
2023-02-09 5:10 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
45,406 | $0 | 929,697 (Direct) |
View |
2023-02-08 Tax Withholding |
2023-02-09 5:10 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
12,547 | $0.5965 | 929,697 (Direct) |
View |
2023-02-07 Option Award |
2023-02-09 5:09 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
18,864 | $0 | 230,191 (Direct) |
View |
2023-02-08 Tax Withholding |
2023-02-09 5:09 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
5,463 | $0.5965 | 230,191 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 8:13 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
42,437 | $0 | 896,838 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-02 8:13 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
11,726 | $0.5952 | 896,838 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 8:12 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
17,631 | $0 | 216,790 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-02 8:12 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
5,841 | $0.5952 | 216,790 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 8:10 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
13,950 | $0 | 223,989 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-02 8:10 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
4,809 | $0.5952 | 223,989 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 8:08 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
21,073 | $0 | 339,882 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-02 8:08 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
5,927 | $0.5952 | 339,882 (Direct) |
View |
2023-01-31 Option Award |
2023-02-02 8:06 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
33,688 | $0 | 537,571 (Direct) |
View |
2023-02-01 Tax Withholding |
2023-02-02 8:06 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
9,321 | $0.5952 | 537,571 (Direct) |
View |
2023-01-24 Option Award |
2023-01-25 5:30 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer |
170,000 | $0 | 205,000 (Direct) |
View |
2023-01-24 Option Award |
2023-01-25 5:29 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President |
170,000 | $0 | 513,204 (Direct) |
View |
2023-01-24 Option Award |
2023-01-25 5:28 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer |
170,000 | $0 | 324,736 (Direct) |
View |
2023-01-24 Option Award |
2023-01-25 5:26 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. |
120,000 | $0 | 214,848 (Direct) |
View |
2023-01-24 Option Award |
2023-01-25 5:25 pm |
N/A N/A |
Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer |
250,000 | $0 | 866,127 (Direct) |
View |